e-Drug3D 1423 |
cas 53016-31-2 |
CLASS GENITO |
ROUTE (list) TRANSDERMAL |
ATC code |
PK parameters Tmax 2 HOUR |
Target TARGET PROGESTERONE RECEPTOR |
DrugCentral Progesterone receptor UNIPROT P06401 PGR |
Download SDF file | 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (17.alpha.)- Formula: Calculated chemical properties: MW 327.45 NB_atoms 24 XLogP 4.14 PSA 50.695 NB_HD 2 NB_HA 3 fsp3 0.76 Lipinski(0=no;1=yes) 1 |
FDA NDA 021180 (label) INN (ETHINYL ESTRADIOL ; NORELGESTROMIN) ORTHO EVRA (JANSSEN PHARMS) APPROVAL= AP YEAR= 2001 DISCONTINUED NDA 200910 (pdf not found) INN (ETHINYL ESTRADIOL ; NORELGESTROMIN) XULANE (MYLAN TECHNOLOGIES) APPROVAL= AP YEAR= 2014 NDA 213950 (pdf not found) INN (ETHINYL ESTRADIOL ; NORELGESTROMIN) ETHINYL ESTRADIOL AND NORELGESTROMIN (AMNEAL) APPROVAL= AP YEAR= 2021 NDA 213977 (pdf not found) INN (ETHINYL ESTRADIOL ; NORELGESTROMIN) ONSURA (TEVA PHARMS USA) APPROVAL= AP YEAR= 2021 NDA 214594 (pdf not found) INN (ETHINYL ESTRADIOL ; NORELGESTROMIN) ETHINYL ESTRADIOL AND NORELGESTROMIN (ZYDUS NOVELTECH INC) APPROVAL= AP YEAR= 2023 |
Other links: |